ErbB2/Her2 (Research Grade Trastuzumab Biosimilar) Biotinylated Antibody
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0478957
- Awardee
- Bio-Techne Sales Corporation
- Contracting organization
- University of Virginia
- Cumulative value
- $389.00
About this award
The University of Virginia awarded contract A207_PO-0478957 to Bio-Techne Sales Corporation on September 10, 2026, for the procurement of specialized research-grade biotechnology products. The contract encompasses the delivery of one unit of ErbB2/Her2 Biotinylated Antibody, specifically a research-grade Trastuzumab biosimilar, to be delivered to Amy S Schienschang at the contracting organization. The total contract value is three hundred eighty-nine dollars ($389), with a unit price of $389 per item.
This procurement represents a Virginia-based state and local contract award executed by the University of Virginia, a public higher education institution. The line item delivery indicates specialized molecular biology research materials necessary for institutional research initiatives. No performance period timeline or specific place of performance location beyond the University of Virginia is specified in the available contract documentation.
Line items
| Item | Total |
|---|---|
| ErbB2/Her2 (Research Grade Trastuzumab Biosimilar) Biotinylated Antibody | $389.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0478957?
Contract A207_PO-0478957 was awarded to Bio-Techne Sales Corporation by University of Virginia on September 10, 2026.
How much is contract A207_PO-0478957 worth?
Its cumulative value is $389.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award